We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.1B
AUM Growth
+$1.98B
Cap. Flow
+$1.34B
Cap. Flow %
8.3%
Top 10 Hldgs %
18.52%
Holding
1,899
New
351
Increased
456
Reduced
282
Closed
805

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$260M
2
BABA icon
Alibaba
BABA
+$229M
3
GILD icon
Gilead Sciences
GILD
+$168M
4
BA icon
Boeing
BA
+$151M
5
ABT icon
Abbott
ABT
+$148M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$306M
2
UNH icon
UnitedHealth
UNH
+$244M
3
VMC icon
Vulcan Materials
VMC
+$146M
4
PEP icon
PepsiCo
PEP
+$98.4M
5
ELV icon
Elevance Health
ELV
+$96.5M

Sector Composition

Rank Sector Weight
1 Healthcare 27.6%
2 Technology 15.66%
3 Consumer Discretionary 13.93%
4 Industrials 11.16%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DVAX
1251
DELISTED
Dynavax Technologies
DVAX
– –
-200,909
Closed -$1.47M
DX
1252
Dynex Capital
DX
$3.21B
– –
-301
Closed -$5K
DXPE icon
1253
DXP Enterprises
DXPE
$2.98B
– –
-10,112
Closed -$393K
DY icon
1254
Dycom Industries
DY
$12.3B
– –
-39,441
Closed -$1.81M
E icon
1255
ENI
E
$77.5B
– –
-100
Closed -$4K
EAF icon
1256
GrafTech
EAF
$212M
– –
-16,615
Closed -$2.13M
EARN
1257
Ellington Residential Mortgage REIT
EARN
$165M
– –
-841
Closed -$10K
EBF icon
1258
Ennis
EBF
$564M
– –
-1,280
Closed -$27K
AXIA
1259
AXIA Energia
AXIA
– –
-28,778
Closed -$213K
EDU icon
1260
New Oriental
EDU
$8.98B
– –
-2,329
Closed -$210K
EFC
1261
Ellington Financial
EFC
$1.71B
– –
-9,760
Closed -$175K
EGBN icon
1262
Eagle Bancorp
EGBN
$845M
– –
-3,760
Closed -$189K
EGO icon
1263
Eldorado Gold
EGO
$9.89B
– –
-57,500
Closed -$266K
EGP icon
1264
EastGroup Properties
EGP
$10.9B
– –
-466
Closed -$52K
EIG icon
1265
Employers Holdings
EIG
$889M
– –
-400
Closed -$16K
ELME
1266
Elme Communities
ELME
$144M
– –
-600
Closed -$17K
EMN icon
1267
Eastman Chemical
EMN
$8.42B
– –
-41,231
Closed -$3.13M
ENOV icon
1268
Enovis
ENOV
$1.53B
– –
-2,731
Closed -$139K
ENVA icon
1269
Enova International
ENVA
$6.29B
– –
-9,042
Closed -$206K
EPAC icon
1270
Enerpac Tool Group
EPAC
$1.93B
– –
-28,852
Closed -$703K
EQH icon
1271
Equitable Holdings
EQH
$14.1B
– –
-870,806
Closed -$17.5M
EQT icon
1272
EQT Corp
EQT
$32.3B
– –
-90,032
Closed -$1.87M
ESNT icon
1273
Essent Group
ESNT
$6.33B
– –
-68,792
Closed -$2.99M
ESPR
1274
DELISTED
Esperion Therapeutics
ESPR
– –
-4,091
Closed -$164K
ESRT icon
1275
Empire State Realty Trust
ESRT
$836M
– –
-4,256
Closed -$67K
49 50
51
52 53

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace North America held 1,899 positions worth $16.1B, up 14% from $14.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America deployed $1.34B of net new capital in Q2 2019, opening 351 new positions and adding to 456 existing holdings. Its largest new stake was Abbott: 1,884,363 shares worth $158M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Pfizer, an estimated $306M trimmed.

  • Marshall Wace North America's largest Q2 2019 buy was Abbott: 1,884,363 shares worth $158M.
  • Marshall Wace North America added most to Meta Platforms (Facebook) in Q2 2019, an estimated $260M increase.
  • Marshall Wace North America's biggest Q2 2019 reduction was Pfizer, cutting an estimated $306M.
  • Marshall Wace North America fully exited UnitedHealth in Q2 2019, selling an estimated $244M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $16.1B portfolio in Q2 2019.
  • Marshall Wace North America opened 351 new positions and closed 805 in Q2 2019.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $16.1B.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.